A research team developed a lung-targeted LNP that specifically delivered the mRNA encoding the normal Tsc2 gene to TSC2-deficient TTJ cells for the treatment of lymphangitic pulmonary fibroids (LAM) caused by Tsc2 gene mutation [53]. This evidence concerns the gene TSC2 and lymphangioleiomyomatosis.